Showing results (1-10 of 634) with videos related to
Sort By:
Pageof 64
Seminars in Oncology|August 27, 2003
Rituximab in B-cell chronic lymphocytic leukemiaThomas S Lin, Margaret S Lucas, John C ByrdJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2007
Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteriaKristie A Blum, Donn Young, Sarah Broering, et al.Seminars in Oncology|April 18, 2006
Treatment of relapsed chronic lymphocytic leukemia: old and new therapiesJohn C Byrd, Thomas S Lin, Michael R GreverBlood|June 26, 2004
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemiaThomas S Lin, Ian W Flinn, Rama Modali, et al.Leukemia & Lymphoma|October 29, 2009
Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemiaThomas S Lin, Louie Naumovski, Philip S Lecane, et al.Clinical Lymphoma & Myeloma|September 26, 2009
Flavopiridol in chronic lymphocytic leukemia: a concise reviewBeth A Christian, Michael R Grever, John C Byrd, et al.Current Opinion in Oncology|October 2, 2007
Flavopiridol in the treatment of chronic lymphocytic leukemiaBeth A Christian, Michael R Grever, John C Byrd, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Consolidation therapy with subcutaneous alemtuzumab after fludarabine and rituximab induction therapy for previously untreated chronic lymphocytic leukemia: final analysis of CALGB 10101Thomas S Lin, Kathleen A Donohue, John C Byrd, et al.Leukemia & Lymphoma|October 29, 2009
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemiaThomas S Lin, Wendy Stock, Huiping Xu, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Chronic lymphocytic leukemia: state of the art and beyondJohn C ByrdPageof 64